Dynavax Technologies | Aktywa



Assets Zmiana Data
AbbVie USD 136.17B 1B 2025-03
Adma Biologics USD 488.68M 98.06M 2024-12
Amgen USD 89.37B 2.47B 2025-03
AstraZeneca USD 112.42B 6.17B 2025-06
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Dynavax Technologies USD 945.93M 40.33M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Merck USD 115.12B 1.98B 2025-03
Neurocrine Biosciences USD 3.69B 31M 2025-03
Novartis USD 104.4B 4.45B 2025-06
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
TG Therapeutics USD 577.69M 8.32M 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12


Dynavax Technologies Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.